| Clinical data | |
|---|---|
| Trade names | Anamidol, Balnimax, Oranabol, Sanaboral, Theranabol, Tubil |
| Other names | Oxymestrone; Ossimesterone; Methandrostenediolone; 4-Hydroxy-17α-methyltestosterone; 17α-Methylandrost-4-en-4,17β-diol-3-one; 4,17β-Dihydroxy-17α-methylandrost-4-en-3-one |
| Routes of administration | By mouth |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.005.134 |
| Chemical and physical data | |
| Formula | C20H30O3 |
| Molar mass | 318.457 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Oxymesterone (INNTooltip International Nonproprietary Name,BANTooltip British Approved Name) (brand namesAnamidol,Balnimax,Oranabol,Sanaboral,Theranabol,Tubil), also known asmethandrostenediolone, as well as4-hydroxy-17α-methyltestosterone or17α-methylandrost-4-en-4,17β-diol-3-one, is anorally activeanabolic-androgenic steroid (AAS).[2][3][4][5] It was known by 1960.[5]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |